These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36410707)

  • 1. Bisphosphonates Alleviate Bone Loss in People with Acute Spinal Cord Injury：A Systematic Review and Meta-Analysis.
    Ma Z; Ma M; He Y; Sun H; Yang B; Dong H; Wang Y
    World Neurosurg; 2023 Feb; 170():e584-e595. PubMed ID: 36410707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.
    Wu Y; Wang F; Zhang Z
    Osteoporos Int; 2021 Jun; 32(6):1117-1127. PubMed ID: 33386876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Bisphosphonates on Managing Osteoporosis After Spinal Cord Injury: A Meta-Analysis.
    Xinghua J; Junjie W; Yao G; Peng S; Jianzhong H
    Curr Pharm Des; 2020; 26(39):5072-5078. PubMed ID: 32364066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
    Bubbear JS; Gall A; Middleton FR; Ferguson-Pell M; Swaminathan R; Keen RW
    Osteoporos Int; 2011 Jan; 22(1):271-9. PubMed ID: 20358358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for steroid-induced osteoporosis.
    Allen CS; Yeung JH; Vandermeer B; Homik J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
    Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post-injury osteoporosis in spinal cord injury patients- a systematic review and meta-analysis.
    Chang KV; Hung CY; Chen WS; Lai MS; Chien KL; Han DS
    PLoS One; 2013; 8(11):e81124. PubMed ID: 24278386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002010. PubMed ID: 24627308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE; Rand MS; Haddock B; Arup S; Smith CD; Jensen JEB; Schwarz P; Hovind P; Oturai PS; Jensen LT; Møller S; Eiken P; Rubin KH; Hitz MF; Abrahamsen B; Jørgensen NR
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
    Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2016 Jan; 27(1):405-10. PubMed ID: 26423406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
    Tan W; Sun J; Zhou L; Li Y; Wu X
    J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for osteoporosis in people with beta-thalassaemia.
    Bhardwaj A; Swe KMM; Sinha NK
    Cochrane Database Syst Rev; 2023 May; 5(5):CD010429. PubMed ID: 37159055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials.
    Lou S; Lv H; Li Z; Zhang L; Tang P
    BMJ Open; 2018 Mar; 8(3):e015187. PubMed ID: 29500198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparisons of bisphosphonates and teriparatide in osteoporosis: a meta-analysis.
    Liu CL; Lee HC; Chen CC; Cho DY
    Clin Invest Med; 2017 Jun; 40(3):E146-E157. PubMed ID: 28653616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.
    Jiang L; Dong J; Wei J; Liu L
    BMC Musculoskelet Disord; 2022 Nov; 23(1):1027. PubMed ID: 36447169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Curcumin on Bone Loss and Biochemical Markers of Bone Turnover in Patients with Spinal Cord Injury.
    Hatefi M; Ahmadi MRH; Rahmani A; Dastjerdi MM; Asadollahi K
    World Neurosurg; 2018 Jun; 114():e785-e791. PubMed ID: 29567290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
    Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
    Shen L; Xie X; Su Y; Luo C; Zhang C; Zeng B
    PLoS One; 2011; 6(10):e26267. PubMed ID: 22022584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.